- Home
- XXII vs SISI Comparison
XXII vs SISI Comparison
Compare XXII & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- SISI
- Stock Information
- Founded
- XXII 1998
- SISI 1997
- Country
- XXII United States
- SISI China
- Employees
- XXII N/A
- SISI N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- SISI Medicinal Chemicals and Botanical Products
- Sector
- XXII Health Care
- SISI Health Care
- Exchange
- XXII Nasdaq
- SISI Nasdaq
- Market Cap
- XXII 6.2M
- SISI 5.6M
- IPO Year
- XXII N/A
- SISI 2016
- Fundamental
- Price
- XXII $1.58
- SISI $5.60
- Analyst Decision
- XXII
- SISI
- Analyst Count
- XXII 0
- SISI 0
- Target Price
- XXII N/A
- SISI N/A
- AVG Volume (30 Days)
- XXII 3.6M
- SISI 97.6K
- Earning Date
- XXII 11-11-2025
- SISI 11-13-2025
- Dividend Yield
- XXII N/A
- SISI N/A
- EPS Growth
- XXII N/A
- SISI N/A
- EPS
- XXII N/A
- SISI N/A
- Revenue
- XXII $21,362,000.00
- SISI $9,601,324.00
- Revenue This Year
- XXII N/A
- SISI N/A
- Revenue Next Year
- XXII $126.57
- SISI N/A
- P/E Ratio
- XXII N/A
- SISI N/A
- Revenue Growth
- XXII N/A
- SISI 1133.26
- 52 Week Low
- XXII $1.51
- SISI $1.00
- 52 Week High
- XXII $613.86
- SISI $271.50
- Technical
- Relative Strength Index (RSI)
- XXII 43.98
- SISI 43.37
- Support Level
- XXII $1.59
- SISI $5.42
- Resistance Level
- XXII $1.77
- SISI $6.27
- Average True Range (ATR)
- XXII 0.15
- SISI 0.61
- MACD
- XXII 0.02
- SISI -0.04
- Stochastic Oscillator
- XXII 15.19
- SISI 12.49
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.